Detection of Chlamydia trachomatis DNA using MagNA Pure DNA extraction and Cobas Amplicor CT/NG amplication

Clinical Microbiology and Infection

Volumn 12, Issue 6, 2006, Pages 576-579

  De Martino, Sylvie J ^a   de Barbeyrac, B ^b   Piemont, Y ^a   Barthel, C ^a   Monteil, H ^a   Jaulhac, B ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Automated DNA extraction; Chlamydia trachomatis; Cobas Amplicor; Detection; Inhibition; MagNA Pure

Indexed keywords

BACTERIAL DNA;

ARTICLE; AUTOMATION; CHLAMYDIA TRACHOMATIS; CLINICAL PROTOCOL; COMPARATIVE STUDY; DEVICE; DNA DETERMINATION; DNA EXTRACTION; GENE AMPLIFICATION; HUMAN; NONHUMAN; PERITONEAL FLUID; PRIORITY JOURNAL; SEMEN ANALYSIS; SENSITIVITY AND SPECIFICITY; TIME; URINALYSIS;

BACTERIA (MICROORGANISMS); CHLAMYDIA TRACHOMATIS;

EID: 33646712072     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01437.x     Document Type: Article

References (11)

1. Centers for Disease Control and Prevention. Recommendations for the prevention and management of Chlamydia trachomatis infections. Morb Mortal Wkly Rep Recomm Rep 1993; 42: 1-39.
2. Dalesio N, Marsiglia V, Quinn A, Quinn TC, Gaydos CA. Performance of the MagNA pure LC robot for extraction of Chlamydia trachomatis and Neisseria gonorrhoeae DNA from urine and swab specimens. J Clin Microbiol 2004; 42: 3300-3302.
3. Raggam RB, Leitner E, Muhlbauer G et al. Qualitative detection of Legionella species in bronchoalveolar lavages and induced sputa by automated DNA extraction and real-time polymerase chain reaction. Med Microbiol Immunol 2002; 191: 119-125.
4. Airell A, Ottosson L, Bygdeman SM et al. Chlamydia trachomatis PCR (Cobas Amplicor) in women: Endocervical specimen transported in a specimen of urine versus endocervical and urethral specimens in 2-SP medium versus urine specimen only. Int J STD AIDS 2000; 11: 651-658.
5. de Barbeyrac B, Geniaux M, Hocke C, Dupon M, Bebear C. Detection of Chlamydia trachomatis in symptomatic and asymptomatic populations with urogenital specimens by AMP CT (Gen-Probe Inc.) compared to other commercially available amplification assays. Diagn Microbiol Infect Dis 2000; 37: 181-185.
6. Mahony J, Chong S, Jang D et al. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction, and transcription-mediated amplification: Identification of urinary substances associated with inhibition and removal of inhibitory activity. J Clin Microbiol 1998; 36: 3122-3126.
7. Pasternack R, Vuorinen P, Miettinen A. Evaluation of the Gen-Probe Chlamydia trachomatis transcription-mediated amplification assay with urine specimens from women. J Clin Microbiol 1997; 35: 676-678.
8. Toye B, Woods W, Bobrowska M, Ramotar K. Inhibition of PCR in genital and urine specimens, submitted for Chlamydia trachomatis testing. J Clin Microbiol 1998; 36: 2356-2358.
9. Van Der Pol B, Quinn TC, Gaydos CA et al. Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis. J Clin Microbiol 2000; 38: 1105-1112.
10. Chan EL, Brandt K, Antonishyn N, Horsman GB. Minimal inhibitory effect of male urine on detection of Chlamydia trachomatis by Roche Amplicor PCR. J Med Microbiol 1999; 48: 215-218.
11. Chan EL, Brandt K, Stoneham H, Antonishyn N, Horsman GB. Comparison of the effectiveness of polymerase chain reaction and enzyme immunoassay in detecting Chlamydia trachomatis in different female genitourinary specimens. Arch Pathol Laboratory Med 2000; 124: 840-843.